Related references
Note: Only part of the references are listed.Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers
Brian A. Gordon et al.
BRAIN (2019)
Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model
Robert J. Andrew et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer's Disease
Katharina Meyer et al.
CELL REPORTS (2019)
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Sven J. van der Lee et al.
ACTA NEUROPATHOLOGICA (2019)
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia
Michael J. Pontecorvo et al.
BRAIN (2019)
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study
Hanna Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease
David Henley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
Nicolai Franzmeier et al.
NATURE COMMUNICATIONS (2019)
A Single-Cell Model for Synaptic Transmission and Plasticity in Human iPSC-Derived Neurons
Marieke Meijer et al.
CELL REPORTS (2019)
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease
James A. R. Nicoll et al.
BRAIN (2019)
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
Clifford R. Jack et al.
BRAIN (2019)
A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ
Dylan Kwart et al.
NEURON (2019)
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease
W. Robert Bell et al.
ALZHEIMERS & DEMENTIA (2019)
Longitudinal tau accumulation and atrophy in aging and alzheimer disease
Theresa M. Harrison et al.
ANNALS OF NEUROLOGY (2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk
Iris E. Jansen et al.
NATURE GENETICS (2019)
Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
Rik Ossenkoppele et al.
NEUROLOGY (2019)
Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
Ruben Smith et al.
JAMA NEUROLOGY (2019)
Microglia in Alzheimer's disease
David V. Hansen et al.
JOURNAL OF CELL BIOLOGY (2018)
Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
Sudeepti Southekal et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
Michael D. Devous et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Prevalence of the apolipoprotein E epsilon 4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2018)
ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
Ioannis Dafnis et al.
BIOCHEMICAL JOURNAL (2018)
Longitudinal tau PET in ageing and Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2018)
Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
Sarah L. DeVos et al.
BRAIN (2018)
Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques
Erin L. Abner et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid- clearance in human astrocytes
Lauren K. Fong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector
Chengzhong Wang et al.
NATURE MEDICINE (2018)
Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals
Heidi I. L. Jacobs et al.
NATURE NEUROSCIENCE (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease
Lawrence S. Honig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH
Hari Prasad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Alzheimer's Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
Siddhartha Mondragon-Rodriguez et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
A transcriptomic atlas of aged human microglia
Marta Olah et al.
NATURE COMMUNICATIONS (2018)
Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease
Yakeel T. Quiroz et al.
JAMA NEUROLOGY (2018)
Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein
Jessica E. Young et al.
STEM CELL REPORTS (2018)
An exploratory clinical study of p38 kinase inhibition in Alzheimer's disease
Philip Scheltens et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Alzheimer's genetic risk is reduced in primary age-related tauopathy: a potential model of resistance?
Corey T. McMillan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
Xianyuan Xiang et al.
MOLECULAR NEURODEGENERATION (2018)
Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
Andrew J. Aschenbrenner et al.
NEUROLOGY (2018)
Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis
Pablo Garcia-Reitboeck et al.
CELL REPORTS (2018)
Presenilin-mediated cleavage of APP regulates synaptotagmin-7 and presynaptic plasticity
Gael Barthet et al.
NATURE COMMUNICATIONS (2018)
Reversal of ApoE4-induced recycling block as a novel prevention a proach for Alzheimer's disease
Xunde Xian et al.
ELIFE (2018)
Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
Alessia Lasorsa et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Microglia and macrophages in brain homeostasis and disease
Qingyun Li et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia
Val J. Lowe et al.
BRAIN (2018)
Bin1 and CD2AP polarise the endocytic generation of beta-amyloid
Florent Ubelmann et al.
EMBO REPORTS (2017)
Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy
Henne Holstege et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Susanne Krasemann et al.
IMMUNITY (2017)
In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds
Natalia Mast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study
Clifford R. Jack et al.
LANCET NEUROLOGY (2017)
Glial contributions to neurodegeneration in tauopathies
Cheryl E. G. Leyns et al.
MOLECULAR NEURODEGENERATION (2017)
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
Shane M. Bemiller et al.
MOLECULAR NEURODEGENERATION (2017)
Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk
Anastasia G. Efthymiou et al.
MOLECULAR NEURODEGENERATION (2017)
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Yang Shi et al.
NATURE (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
Generation of pure GABAergic neurons by transcription factor programming
Nan Yang et al.
NATURE METHODS (2017)
The association between tau PET and retrospective cortical thinning in clinically normal elderly
Molly R. LaPoint et al.
NEUROIMAGE (2017)
Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults
Ge Li et al.
NEUROLOGY (2017)
In vivo staging of regional amyloid deposition
Michel J. Grothe et al.
NEUROLOGY (2017)
Hallmarks of Alzheimer's Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain
Ira Espuny-Camacho et al.
NEURON (2017)
Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
Natalia Mast et al.
NEUROPHARMACOLOGY (2017)
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
Cheryl E. G. Leyns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
Sarah L. DeVos et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Susanne Ostrowitzki et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease
Takayuki Kondo et al.
CELL REPORTS (2017)
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease
Julie M. Zissimopoulos et al.
JAMA NEUROLOGY (2017)
The Endosomal-Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo
Tal Nuriel et al.
FRONTIERS IN NEUROSCIENCE (2017)
Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease
Philip W. Brownjohn et al.
STEM CELL REPORTS (2017)
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
Alexandre Bejanin et al.
BRAIN (2017)
APP mouse models for Alzheimer's disease preclinical studies
Hiroki Sasaguri et al.
EMBO JOURNAL (2017)
Distinct 18F-AV-1451 tau PET retention patterns in early-and late-onset Alzheimer's disease
Michael Scholl et al.
BRAIN (2017)
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Fluorodeoxyglucose Metabolism Associated With Tau-Amyloid Interaction Predicts Memory Decline
Bernard J. Hanseeuw et al.
ANNALS OF NEUROLOGY (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease
S. Kim et al.
MOLECULAR PSYCHIATRY (2016)
Tau in physiology and pathology
Yipeng Wang et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology
Inger Lauritzen et al.
ACTA NEUROPATHOLOGICA (2016)
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz et al.
BRAIN (2016)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence
Yu Yamazaki et al.
CNS DRUGS (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity
Kyle W. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The amyloid cascade hypothesis: are we poised for success or failure?
Eric Karran et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
John M. Ringman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
Teng Jiang et al.
NEUROPHARMACOLOGY (2016)
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations
Grace Woodruff et al.
CELL REPORTS (2016)
PART is part of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2015)
Regional brain hypometabolism is unrelated to regional amyloid plaque burden
Andre Altmann et al.
BRAIN (2015)
Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
Nicole Maphis et al.
BRAIN (2015)
Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration
Lucy Liu et al.
CELL (2015)
Elucidating Molecular Phenotypes Caused by the SORL1 Alzheimer's Disease Genetic Risk Factor Using Human Induced Pluripotent Stem Cells
Jessica E. Young et al.
CELL STEM CELL (2015)
Cellular Functions of the Amyloid Precursor Protein from Development to Dementia
Rik van der Kant et al.
DEVELOPMENTAL CELL (2015)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
Erik S. Musiek et al.
NATURE NEUROSCIENCE (2015)
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Hirohide Asai et al.
NATURE NEUROSCIENCE (2015)
Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice
Teng Jiang et al.
NEUROBIOLOGY OF AGING (2015)
Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease
Ashish Raj et al.
CELL REPORTS (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons
Christina R. Muratore et al.
HUMAN MOLECULAR GENETICS (2014)
Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice
Natalia Mast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Reversal of apoE4-Driven Brain Pathology and Behavioral Deficits by Bexarotene
Anat Boehm-Cagan et al.
JOURNAL OF NEUROSCIENCE (2014)
A three-dimensional human neural cell culture model of Alzheimer's disease
Se Hoon Choi et al.
NATURE (2014)
Pharmacological chaperones stabilize retromer to limit APP processing
Vincent J. Mecozzi et al.
NATURE CHEMICAL BIOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Exercise, APOE genotype, and the evolution of the human lifespan
David A. Raichlen et al.
TRENDS IN NEUROSCIENCES (2014)
Stuck in traffic: an emerging theme in diseases of the nervous system
Jacques Neefjes et al.
TRENDS IN NEUROSCIENCES (2014)
Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase
Kunihiko Kanatsu et al.
NATURE COMMUNICATIONS (2014)
PICALM modulates autophagy activity and tau accumulation
Kevin Moreau et al.
NATURE COMMUNICATIONS (2014)
SnapShot: Genetics of Alzheimer's Disease
Rita Guerreiro et al.
CELL (2013)
Modeling Alzheimer's Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness
Takayuki Kondo et al.
CELL STEM CELL (2013)
Normal cognition in transgenic BRI2-Aβ mice
Jungsu Kim et al.
MOLECULAR NEURODEGENERATION (2013)
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
J. Chapuis et al.
MOLECULAR PSYCHIATRY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
Yingsha Zhang et al.
NEURON (2013)
Biomarker Modeling of Alzheimer's Disease
Clifford R. Jack et al.
NEURON (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Ina Tesseur et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Karthikeyan Veeraraghavalu et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Ashleigh R. Price et al.
SCIENCE (2013)
Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease
Robin B. Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis
Qingli Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells
Mason A. Israel et al.
NATURE (2012)
The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol
Paul J. Barrett et al.
SCIENCE (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Cholesterol Level and Statin Use in Alzheimer Disease I. Review of Epidemiological and Preclinical Studies
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Cholesterol Level and Statin Use in Alzheimer Disease II. Review of Human Trials and Recommendations
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice
Tomoko Kurata et al.
BRAIN RESEARCH (2011)
Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors
Jens Brodbeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)
Adam D. Bachstetter et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Linking lipids to Alzheimer's disease: cholesterol and beyond
Gilbert Di Paolo et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Plasma apolipoprotein E and Alzheimer disease risk The AIBL study of aging
V. B. Gupta et al.
NEUROLOGY (2011)
ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1
Ragna Sannerud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models
Sungho Lee et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance
Mitsuru Shinohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis
Zhiqiang Liu et al.
JOURNAL OF NEUROSCIENCE (2010)
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Kiran Bhaskar et al.
NEURON (2010)
Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway
Henri J. Huttunen et al.
FASEB JOURNAL (2009)
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
Robert W. Mahley et al.
JOURNAL OF LIPID RESEARCH (2009)
Statins Reduce the Neurofibrillary Tangle Burden in a Mouse Model of Tauopathy
Moran Boimel et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
APOE genotype-specific differences in the innate immune response
Michael P. Vitek et al.
NEUROBIOLOGY OF AGING (2009)
ACAT as a drug target for Alzheimer's disease
Henri J. Huttunen et al.
NEURODEGENERATIVE DISEASES (2008)
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Scott A. Small et al.
NEURON (2008)
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Aβ accumulation
Alim Muhammad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Induction of tau pathology by intracerebral infusion of amyloid-β-containing brain extract and by amyloid-β deposition in APP x tau transgenic mice
Tristan Bolmont et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2007)
Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: Effects of gender, CYP46, and ApoE polymorphisms
Gloria Lena Vega et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Reduction of soluble Aβ and Tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles
Salvatore Oddo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Aβ species removal after Aβ42 immunization
James A. R. Nicoll et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
The lipoprotein receptor LR11 regulates amyloid β production and amyloid precursor protein traffic in endosomal compartments
K Offe et al.
JOURNAL OF NEUROSCIENCE (2006)
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells:: ApoE structure as a potential therapeutic target
SM Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Model-guided microarray implicates the retromer complex in Alzheimer's disease
SA Small et al.
ANNALS OF NEUROLOGY (2005)
Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory
RL Buckner et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease
B Hutter-Paier et al.
NEURON (2004)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
CNS synaptogenesis promoted by glia-derived cholesterol
DH Mauch et al.
SCIENCE (2001)
Acyl-coenzyme A:cholesterol acyltransferase modulates the generation of the amyloid β-peptide
L Puglielli et al.
NATURE CELL BIOLOGY (2001)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
Share Paper
